[go: up one dir, main page]

AU2001288957A1 - Inhibition of adenovirus replication by product r, a peptide nucleic acid immunomodulator - Google Patents

Inhibition of adenovirus replication by product r, a peptide nucleic acid immunomodulator

Info

Publication number
AU2001288957A1
AU2001288957A1 AU2001288957A AU8895701A AU2001288957A1 AU 2001288957 A1 AU2001288957 A1 AU 2001288957A1 AU 2001288957 A AU2001288957 A AU 2001288957A AU 8895701 A AU8895701 A AU 8895701A AU 2001288957 A1 AU2001288957 A1 AU 2001288957A1
Authority
AU
Australia
Prior art keywords
inhibition
product
nucleic acid
peptide nucleic
adenovirus replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288957A
Inventor
Shalom Z. Hirschman
Wenlin Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Viral Research Corp
Original Assignee
Advanced Viral Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Viral Research Corp filed Critical Advanced Viral Research Corp
Publication of AU2001288957A1 publication Critical patent/AU2001288957A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001288957A 2000-09-08 2001-09-07 Inhibition of adenovirus replication by product r, a peptide nucleic acid immunomodulator Abandoned AU2001288957A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23107300P 2000-09-08 2000-09-08
US60231073 2000-09-08
PCT/US2001/028212 WO2002020043A1 (en) 2000-09-08 2001-09-07 Inhibition of adenovirus replication by product r, a peptide nucleic acid immunomodulator

Publications (1)

Publication Number Publication Date
AU2001288957A1 true AU2001288957A1 (en) 2002-03-22

Family

ID=22867644

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288957A Abandoned AU2001288957A1 (en) 2000-09-08 2001-09-07 Inhibition of adenovirus replication by product r, a peptide nucleic acid immunomodulator

Country Status (3)

Country Link
US (1) US20020081627A1 (en)
AU (1) AU2001288957A1 (en)
WO (1) WO2002020043A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528098B2 (en) 1996-10-22 2003-03-04 Advanced Viral Research Corp. Preparation of a therapeutic composition
US20040033244A1 (en) * 2002-05-28 2004-02-19 Advanced Viral Research, Corp. Treatment of cancers of lymphocytic cells with product R
US20090305944A1 (en) * 2005-06-03 2009-12-10 Bbm Holdings, Inc Methods for Providing Palliative Care with AVR 118

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071715A (en) * 1993-08-12 2000-06-06 Board Of Regents, The University Of Texas System Nucleic acids encoding novel proteins which bind to retinoblastoma protein

Also Published As

Publication number Publication date
US20020081627A1 (en) 2002-06-27
WO2002020043A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001278740A1 (en) Novel phenylalanine derivatives
AU2002219555A1 (en) VLA-4 Inhibitors
AU2001283202A1 (en) User-directed product recommendations
AU2001296961A1 (en) 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AU3404901A (en) Constructive nanolithography
AU5439401A (en) Product pusher
AU2001235664A1 (en) Product sale process management system
AU2001242743A1 (en) Novel phenylalanine derivative
AU2001245722A1 (en) Improved separation processes
AU2002215167A1 (en) Undercoating for concrete
AU2001252502A1 (en) Displacement sensing system
AU2001262525A1 (en) A drink product
AU2002323752A1 (en) Microorganism overproducing 5'-xanthylic acid
AU2002245107A1 (en) Improved biochip
AU2001261476A1 (en) Nucleic acid sequences for novel gpcrs
AU2001273461A1 (en) Methods for recombinatorial nucleic acid synthesis
AU2001288957A1 (en) Inhibition of adenovirus replication by product r, a peptide nucleic acid immunomodulator
AU5903000A (en) Novel anti-thrombin peptide
AU2001292301A1 (en) Novel drugs for liver diseases
AUPQ596600A0 (en) Point of sale system
AU2001288473A1 (en) Stack of goods
AU2001293697A1 (en) N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
AU2001292578A1 (en) Pharmaceutical compounds
WO2001074787A3 (en) Crystalline pharmaceutical
AU7275100A (en) Vegetal peptones for dna production